Microdosing Psychedelic LSD for Alzheimer’s Safe in Early Human Trial

According to the new study, Phase 1 trial is the first level in testing whether certain kinds of experimental microdose techniques could be beneficial as a therapeutic approach for treating Alzheimer’s disease.